SCHEMBL20022717

SCHEMBL20022717

O=c1[nH]sc2c(Cl)cccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ CACNA1B Q00975 2/20 0.48
▸ APBA1 Q02410 2/20 0.48
▸ DDAH1 O94760 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ CASP3 P42574 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ DAO P14920 2/20 0.46
▸ PARP1 P09874 3/20 0.44
▸ DYRK1A Q13627 2/20 0.44
▸ AURKA O14965 1/20 0.44
▸ DAPK3 O43293 1/20 0.44
▸ JAK2 O60674 1/20 0.44
▸ PRKD3 O94806 1/20 0.44
▸ MAP4K4 O95819 1/20 0.44
▸ PAK4 O96013 1/20 0.44
▸ ABL1 P00519 1/20 0.44
▸ CSF1R P07333 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9455748 0.78 ALDH1A1 (0.50) KDM4EMAPTCACNA1BAPBA1DDAH1
SCHEMBL6232605 0.76 ALDH1A1 (0.48) KDM4EMAPTCACNA1BAPBA1DDAH1
SCHEMBL1412268 0.76 ALDH1A1 (0.48) KDM4EMAPTCACNA1BAPBA1DDAH1
SCHEMBL11539582 0.73 PARP1 (0.44) KDM4EMAPTLMNACASP3DAO
SCHEMBL31288017 0.72 CA1 (0.44) KDM4EMAPTCACNA1BAPBA1DDAH1
SCHEMBL20022719 0.72 KDM4E (0.48) KDM4EMAPTCACNA1BAPBA1DDAH1
SCHEMBL292306 0.68 ALDH1A1 (0.41) KDM4EMAPTCACNA1BAPBA1DDAH1
SCHEMBL11372514 0.68 CYP1A2 (0.46) KDM4EMAPTLMNADAOPARP1
SCHEMBL2970289 0.68 MAPT (0.48) KDM4EMAPTCACNA1BAPBA1DDAH1
SCHEMBL8394428 0.67 KDM4E (0.47) KDM4EMAPTCACNA1BAPBA1DDAH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180092908-A1 SMALL MOLECULE OXIDIZERS OF PDI AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2018-04-05 — — US disclosed
US-20180092908-A1 SMALL MOLECULE OXIDIZERS OF PDI AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2018-04-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180092908-A1 SMALL MOLECULE OXIDIZERS OF PDI AND THEIR USE PDIA5, PDIA4, PDIA6 KDM4E 4750/4885MAPT 183/4885CACNA1B 3359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback